A randomized, double-masked, placebo-controlled parallel study of loteprednol etabonate 0.2% in patients with seasonal allergic conjunctivitis11None of the investigators had a proprietary interest in loteprednol etabonate.
Authors:
- Larry L LothringerLLLarry L Lothringer
- Jay M RubinJRJay M Rubin
- Richard B BriggsRBRichard B Briggs
- John HowesJHJohn Howes
- Gary D NovackGary D Novack
- Kathryn HartKHKathryn Hart
- 1 February 1999
- journal article
- clinical trial
- Published by Elsevier in Ophthalmology
- Vol. 106 (2) , 362-369
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The Conjunctival Provocation Test Model of Ocular Allergy: Utility for Assessment of an Ocular Corticosteroid, Loteprednol EtabonateJournal of Ocular Pharmacology and Therapeutics, 1998
- Double-masked, placebo-controlled evaluation of loteprednol etabonate 0.5 for postoperative inflammationJournal of Cataract & Refractive Surgery, 1998
- A double-masked, placebo-controlled evaluation of 0.5% loteprednol etabonate in the treatment of postoperative inflammation, ,Ophthalmology, 1998
- Change in Intraocular Pressure During Long-Term Use of Loteprednol EtabonateJournal of Glaucoma, 1998
- Failure to Detect Systemic Levels, and Effects of Loteprednol Etabonate and its Metabolite, PJ-91, Following Chronic Ocular AdministrationJournal of Ocular Pharmacology and Therapeutics, 1998
- A Controlled Evaluation of the Efficacy and Safety of Loteprednol Etabonate in the Prophylactic Treatment of Seasonal Allergic ConjunctivitisAmerican Journal of Ophthalmology, 1997
- A Double-masked, Placebo-controlled Evaluation of the Efficacy and Safety of Loteprednol Etabonate in the Treatment of Giant Papillary ConjunctivitisAmerican Journal of Ophthalmology, 1997
- Ocular absorption and distribution of loteprednol etabonate, a soft steroid, in rabbit eyesCurrent Eye Research, 1991
- LevocabastineOphthalmology, 1988
- Soft drugs: Principles and methods for the design of safe drugsMedicinal Research Reviews, 1984